Rigel Pharmaceuticals reported $41.33M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acceleron Pharma XLRN:US $ 104.83M 13.23M
Acura Pharmaceuticals ACUR:US 913K 123K
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Amgen AMGN:US $ 4.33B 1.37B
Anika Therapeutics ANIK:US $ 38.24M 9.27M
Applied Genetic Technologies AGTC:US $ 16.42M 2.14M
Arrowhead Research ARWR:US $ 103.17M 25.41M
Astrazeneca AZN:US 11.54B 4.45B
AstraZeneca AZN:LN 11.54B 4.45B
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Bristol Myers Squibb BMY:US $ 9.63B 360M
Celldex Therapeutics CLDX:US $ 20.98M 4.06M
Chemocentryx CCXI:US $ 39.55M 1M
Daiichi Sankyo 4568:JP 226.92B 8.62B
Dicerna Pharmaceuticals DRNA:US $ 83.23M 1.64M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Flexion Therapeutics FLXN:US $ 44.98M 73K
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Heron Therapeutics HRTX:US $ 74.94M 7.97M
Immunogen IMGN:US $ 43.44M 873K
Intrexon XON:US $ 47.03M 2.22M
IONIS PHARMACEUT IONS:US $ 219M 11.65M
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Ligand Pharmaceuticals LGND:US $ 49.23M 7.99M
Macrogenics MGNX:US $ 68.65M 2.39M
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Pfizer PFE:US $ 16447M 3384M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Rigel Pharmaceuticals RIGL:US $ 41.33M 2.01M
Sangamo Biosciences SGMO:US $ 77M 427K
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M
Veracyte VCYT:US $ 77.05M 14.47M